Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Gradishar

Showing results (121-130 of 195) with videos related to

Pageof 20
Sort By:
Oncotarget|February 7, 2022
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancersAmi N Shah, Ashwin Sunderraj, Brian Finkelman, et al.
Journal of the National Cancer Institute|January 27, 2021
The Global Landscape of Treatment Standards for Breast CancerDario Trapani, Jean Yves Douillard, Eric P Winer, et al.
Ebiomedicine|July 25, 2020
Landscape of circulating tumour DNA in metastatic breast cancerAndrew A Davis, Saya Jacob, Lorenzo Gerratana, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2020
Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy toolsLorenzo Gerratana, Andrew A Davis, Maurizio Polano, et al.
Breast Cancer Research and Treatment|June 2, 2021
Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancerAmi N Shah, Kristen J Carroll, Lorenzo Gerratana, et al.
Journal of Clinical and Experimental Neuropsychology|January 22, 2026
Functional dysconnectivity in breast cancer patients undergoing hormone therapyJulie Petersen, Sonya V Gupta, Alexandra C Apple, et al.
Science Advances|January 6, 2023
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicityZiyi Fu, Siqi Chen, Yueming Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast CancerSaya Jacob, Andrew A Davis, Lorenzo Gerratana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine TherapyWilliam J Gradishar, Denise A Yardley, Rachel Layman, et al.
JAMA Oncology|March 23, 2018
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical TrialMelanie Royce, Thomas Bachelot, Cristian Villanueva, et al.
Pageof 20

Showing results (121-130 of 195) with videos related to

Sort By:
Pageof 20
Oncotarget|February 7, 2022
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancersAmi N Shah, Ashwin Sunderraj, Brian Finkelman, et al.
Journal of the National Cancer Institute|January 27, 2021
The Global Landscape of Treatment Standards for Breast CancerDario Trapani, Jean Yves Douillard, Eric P Winer, et al.
Ebiomedicine|July 25, 2020
Landscape of circulating tumour DNA in metastatic breast cancerAndrew A Davis, Saya Jacob, Lorenzo Gerratana, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2020
Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy toolsLorenzo Gerratana, Andrew A Davis, Maurizio Polano, et al.
Breast Cancer Research and Treatment|June 2, 2021
Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancerAmi N Shah, Kristen J Carroll, Lorenzo Gerratana, et al.
Journal of Clinical and Experimental Neuropsychology|January 22, 2026
Functional dysconnectivity in breast cancer patients undergoing hormone therapyJulie Petersen, Sonya V Gupta, Alexandra C Apple, et al.
Science Advances|January 6, 2023
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicityZiyi Fu, Siqi Chen, Yueming Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast CancerSaya Jacob, Andrew A Davis, Lorenzo Gerratana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine TherapyWilliam J Gradishar, Denise A Yardley, Rachel Layman, et al.
JAMA Oncology|March 23, 2018
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical TrialMelanie Royce, Thomas Bachelot, Cristian Villanueva, et al.
Pageof 20